Provided by Tiger Fintech (Singapore) Pte. Ltd.

Altimmune, Inc.

4.85
+0.06001.25%
Post-market: 4.850.00000.00%16:30 EDT
Volume:1.80M
Turnover:8.65M
Market Cap:373.52M
PE:-3.62
High:4.94
Open:4.88
Low:4.71
Close:4.79
Loading ...
Aug 31, 2021

Beneficial Ownership Change

Altimmune, Inc.
Aug 31, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 10, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 17, 2021

Major Issues Report

8-K - Current report
Apr 01, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 25, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 23, 2020

Major Issues Report

8-K - Current report